{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T06:49:17Z","timestamp":1784357357020,"version":"3.55.0"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2019,1,31]],"date-time":"2019-01-31T00:00:00Z","timestamp":1548892800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The chronic aspects of leprosy are discussed here. They are a consequence of the peripheral nerve damage that affects many patients during their lifetime with leprosy. The peripheral nerve damage leaves people unable to feel and with weakness in their hands and feet. They are at risk of damaging their hands and feet, causing the disabilities and deformities that characterise late leprosy.<\/jats:p><jats:p>More than 200 000 new leprosy patients are diagnosed globally each year. Better data are needed from cohort studies to estimate the number of patients developing nerve damage and modelling studies are needed to estimate the number of patients who develop disabilities. For some of them, this will be a lifelong disability.<\/jats:p><jats:p>Nerve damage is caused by inflammation in leprosy-affected nerves. Patients with nerve damage of &amp;lt;6-mo duration need treatment with steroids. About 66% of multibacillary patients will develop nerve damage. Plastic graded monofilaments can be used to detect nerve damage in leprosy and diabetic clinics. Assessing nerve damage and treating patients with steroids in leprosy programmes needs to be strengthened. The World Health Organization has a successful programme for supplying antibiotics for treating leprosy infection to national leprosy programmes. They should take responsibility for providing steroids to national programmes since this is a core part of the treatment for &amp;gt;66% of multibacillary patients. Patients need to be asked about neuropathic pain symptoms and treated if necessary.<\/jats:p><jats:p>Treated leprosy patients are at risk of developing ulcers in their feet. Treatment and prevention needs to be improved through health education, providing protective footwear and patient empowerment.<\/jats:p>","DOI":"10.1093\/trstmh\/try131","type":"journal-article","created":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T20:13:13Z","timestamp":1543349593000},"page":"813-817","source":"Crossref","is-referenced-by-count":21,"title":["Chronic aspects of leprosy\u2014neglected but important"],"prefix":"10.1093","volume":"113","author":[{"given":"Diana N J","family":"Lockwood","sequence":"first","affiliation":[{"name":"Professor of Tropical Medicine, London School of Hygiene and Tropical Medicine, Keppel St London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,1,31]]},"reference":[{"key":"2019121207371564900_try131C1"},{"issue":"2","key":"2019121207371564900_try131C2","doi-asserted-by":"crossref","first-page":"131","DOI":"10.47276\/lr.75.2.131","article-title":"Inter-rater reliability of WHO \u2018disability\u2019 grading","volume":"75","author":"Brandsma","year":"2004","journal-title":"Lepr Rev"},{"issue":"35","key":"2019121207371564900_try131C3","first-page":"501","article-title":"Global leprosy update, 2016: accelerating reduction of disease burden","volume":"92","author":"World Health Organization","year":"2017","journal-title":"Wkly Epidemiol Rec"},{"issue":"3","key":"2019121207371564900_try131C4","first-page":"344","article-title":"The hand-foot impairment score as a tool for evaluating prevention of disability activities in leprosy: an exploration in patients treated with corticosteroids","volume":"71","author":"Broekhuis","year":"2000","journal-title":"Lepr Rev"},{"key":"2019121207371564900_try131C5","first-page":"1","article-title":"Chemotherapy of leprosy for control programmes","volume":"675","author":"World Health Organization","year":"1982","journal-title":"World Health Org Tech Rep Ser"},{"issue":"7","key":"2019121207371564900_try131C6","doi-asserted-by":"crossref","first-page":"e0005725","DOI":"10.1371\/journal.pntd.0005725","article-title":"Uniform multidrug therapy for leprosy patients in Brazil (U-MDT\/CT-BR): results of an open label, randomized and controlled clinical trial, among multibacillary patients","volume":"11","author":"Penna","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"2019121207371564900_try131C7","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0363-5023(87)80189-2","article-title":"The repeatability of testing with Semmes-Weinstein monofilaments","volume":"12","author":"Bell-Krotoski","year":"1987","journal-title":"J Hand Surg"},{"issue":"9215","key":"2019121207371564900_try131C8","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/S0140-6736(00)02216-9","article-title":"A clinical prediction rule for nerve-function impairment in leprosy patients","volume":"355","author":"Croft","year":"2000","journal-title":"Lancet"},{"issue":"3","key":"2019121207371564900_try131C9","first-page":"285","article-title":"The pattern of leprosy-related neuropathy in the AMFES patients in Ethiopia: definitions, incidence, risk factors and outcome","volume":"71","author":"Saunderson","year":"2000","journal-title":"Lepr Rev"},{"issue":"4","key":"2019121207371564900_try131C10","doi-asserted-by":"crossref","first-page":"277","DOI":"10.47276\/lr.76.4.277","article-title":"The INFIR Cohort Study: assessment of sensory and motor neuropathy in leprosy at baseline","volume":"76","author":"Van Brakel","year":"2005","journal-title":"Lepr Rev"},{"issue":"1","key":"2019121207371564900_try131C11","first-page":"1","article-title":"Delay in presentation and start of treatment in leprosy patients: a case-control study of disabled and non-disabled patients in three different settings in Ethiopia","volume":"66","author":"Bekri","year":"1998","journal-title":"Int J Lepr Other Mycobact Dis"},{"issue":"2","key":"2019121207371564900_try131C12","first-page":"158","article-title":"Dynamics of impairment during and after treatment: the AMFES cohort","volume":"72","author":"Meima","year":"2001","journal-title":"Lepr Rev"},{"issue":"1","key":"2019121207371564900_try131C13","doi-asserted-by":"crossref","first-page":"25","DOI":"10.47276\/lr.77.1.25","article-title":"Multi-centre, double blind, randomized trial of three steroid regimens in the treatment of type-1 reactions in leprosy","volume":"77","author":"Rao","year":"2006","journal-title":"Lepr Rev"},{"issue":"4","key":"2019121207371564900_try131C14","doi-asserted-by":"crossref","first-page":"311","DOI":"10.47276\/lr.74.4.311","article-title":"Treatment with corticosteroids of long-standing nerve function impairment in leprosy: a randomized controlled trial (TRIPOD 3)","volume":"74","author":"Richardus","year":"2003","journal-title":"Lepr Rev"},{"issue":"3","key":"2019121207371564900_try131C15","doi-asserted-by":"crossref","first-page":"e0005348","DOI":"10.1371\/journal.pntd.0005348","article-title":"AZALEP a randomized controlled trial of azathioprine to treat leprosy nerve damage and type 1 reactions in India: main findings","volume":"11","author":"Lockwood","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"issue":"4","key":"2019121207371564900_try131C16","doi-asserted-by":"crossref","first-page":"e1041","DOI":"10.1371\/journal.pntd.0001041","article-title":"A phase two randomised controlled double blind trial of high dose intravenous methylprednisolone and oral prednisolone versus intravenous normal saline and oral prednisolone in individuals with leprosy type 1 reactions and\/or nerve function impairment","volume":"5","author":"Walker","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"2019121207371564900_try131C17","doi-asserted-by":"crossref","first-page":"e0004149","DOI":"10.1371\/journal.pntd.0004149","article-title":"Comparison of efficacy and safety of ciclosporin to prednisolone in the treatment of erythema nodosum leprosum: two randomised, double blind, controlled pilot studies in Ethiopia","volume":"10","author":"Lambert","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"issue":"10","key":"2019121207371564900_try131C18","doi-asserted-by":"crossref","first-page":"e0005952","DOI":"10.1371\/journal.pntd.0005952","article-title":"Effectiveness of 32 versus 20 weeks of prednisolone in leprosy patients with recent nerve function impairment: a randomized controlled trial","volume":"11","author":"Wagenaar","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"issue":"4","key":"2019121207371564900_try131C19","doi-asserted-by":"crossref","first-page":"319","DOI":"10.47276\/lr.74.4.319","article-title":"Adverse events of standardized regimens of corticosteroids for prophylaxis and treatment of nerve function impairment in leprosy: results from the \u2018TRIPOD\u2019 trials","volume":"74","author":"Richardus","year":"2003","journal-title":"Lepr Rev"},{"issue":"9","key":"2019121207371564900_try131C20","doi-asserted-by":"crossref","first-page":"e0004065","DOI":"10.1371\/journal.pntd.0004065","article-title":"ENLIST 1: an international multi-centre cross-sectional study of the clinical features of erythema nodosum leprosum","volume":"9","author":"Walker","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"2019121207371564900_try131C21","doi-asserted-by":"crossref","first-page":"221","DOI":"10.47276\/lr.87.2.221","article-title":"The use of steroids and thalidomide in the management of erythema nodosum leprosum; 17 years at the Hospital for Tropical Diseases, London","volume":"87","author":"Nabarro","year":"2016","journal-title":"Lepr Rev"},{"issue":"3","key":"2019121207371564900_try131C22","doi-asserted-by":"crossref","first-page":"e2690","DOI":"10.1371\/journal.pntd.0002690","article-title":"The mortality associated with erythema nodosum leprosum in Ethiopia: a retrospective hospital-based study","volume":"8","author":"Walker","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"2019121207371564900_try131C23","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1440-0960.2009.00534.x","article-title":"Comparative efficacy of thalidomide and prednisolone in the treatment of moderate to severe erythema nodosum leprosum: a randomized study","volume":"50","author":"Kaur","year":"2009","journal-title":"Australas J Dermatol"},{"issue":"1","key":"2019121207371564900_try131C24","first-page":"29","article-title":"Comparative efficacy of four treatment regimens in type 2 leprosy reactions (prednisolone alone, thalidomide alone, prednisolone plus thalidomide and prednisolone plus clofazimine)","volume":"88","author":"Kar","year":"2016","journal-title":"Indian J Lepr"},{"issue":"10","key":"2019121207371564900_try131C25","doi-asserted-by":"crossref","first-page":"e479","DOI":"10.1016\/S2352-3026(18)30149-2","article-title":"Thalidomide before and after autologous stem cell transplantation in recently diagnosed multiple myeloma (HOVON-50): long-term results from the phase 3, randomised controlled trial","volume":"5","author":"van de Donk","year":"2018","journal-title":"Lancet Haematol"},{"issue":"7","key":"2019121207371564900_try131C26","doi-asserted-by":"crossref","first-page":"e0005716","DOI":"10.1371\/journal.pntd.0005716","article-title":"A leprosy clinical severity scale for erythema nodosum leprosum: an international, multicentre validation study of the ENLIST ENL Severity Scale","volume":"11","author":"Walker","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"issue":"4","key":"2019121207371564900_try131C27","doi-asserted-by":"crossref","first-page":"488","DOI":"10.47276\/lr.88.4.488","article-title":"Health-related quality of life amongst people affected by erythema nodosum leprosum in Bangladesh: a cross sectional study","volume":"88","author":"Bowers","year":"2017","journal-title":"Lepr Rev"},{"issue":"4","key":"2019121207371564900_try131C28","doi-asserted-by":"crossref","first-page":"499","DOI":"10.47276\/lr.88.4.499","article-title":"The impact of erythema nodosum leprosum on health related quality of life in Rio de Janeiro","volume":"88","author":"Sales","year":"2017","journal-title":"Lepr Rev"},{"issue":"3","key":"2019121207371564900_try131C29","doi-asserted-by":"crossref","first-page":"270","DOI":"10.47276\/lr.79.3.270","article-title":"Neuropathic pain in people treated for multibacillary leprosy more than ten years previously","volume":"79","author":"Saunderson","year":"2008","journal-title":"Lepr Rev"},{"issue":"8","key":"2019121207371564900_try131C30","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1016\/j.pain.2012.04.007","article-title":"Investigation of neuropathic pain in treated leprosy patients in Ethiopia: a cross-sectional study","volume":"153","author":"Haroun","year":"2012","journal-title":"Pain"},{"issue":"3","key":"2019121207371564900_try131C31","doi-asserted-by":"crossref","first-page":"e981","DOI":"10.1371\/journal.pntd.0000981","article-title":"Neuropathic pain and psychological morbidity in patients with treated leprosy: a cross-sectional prevalence study in Mumbai","volume":"5","author":"Lasry-Levy","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"issue":"4","key":"2019121207371564900_try131C32","doi-asserted-by":"crossref","first-page":"369","DOI":"10.47276\/lr.78.4.369","article-title":"Histopathological and clinical findings in leprosy patients with chronic neuropathic pain: a study from Hyderabad, India","volume":"78","author":"Lund","year":"2007","journal-title":"Lepr Rev"},{"issue":"7","key":"2019121207371564900_try131C33","doi-asserted-by":"crossref","first-page":"e0006610","DOI":"10.1371\/journal.pntd.0006610","article-title":"Diagnosis and impact of neuropathic pain in leprosy patients in Nepal after completion of multidrug therapy","volume":"12","author":"Toh","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"issue":"1\u20132","key":"2019121207371564900_try131C34","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.pain.2004.12.010","article-title":"Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4)","volume":"114","author":"Bouhassira","year":"2005","journal-title":"Pain"},{"issue":"2","key":"2019121207371564900_try131C35","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(14)70251-0","article-title":"Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis","volume":"14","author":"Finnerup","year":"2015","journal-title":"Lancet Neurol"},{"issue":"1","key":"2019121207371564900_try131C36","doi-asserted-by":"crossref","first-page":"e0003431","DOI":"10.1371\/journal.pntd.0003431","article-title":"Household costs of leprosy reactions (ENL) in rural India","volume":"9","author":"Chandler","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"2019121207371564900_try131C37","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1186\/s12879-017-2869-8","article-title":"Evaluation of the economic burden of leprosy among migrant and resident patients in Guangdong Province, China","volume":"17","author":"Xiong","year":"2017","journal-title":"BMC Infect Dis"}],"container-title":["Transactions of The Royal Society of Tropical Medicine and Hygiene"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/trstmh\/article-pdf\/113\/12\/813\/31501656\/try131.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/trstmh\/article-pdf\/113\/12\/813\/31501656\/try131.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T03:37:01Z","timestamp":1605497821000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/trstmh\/article\/113\/12\/813\/5304753"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,31]]},"references-count":37,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2019,1,31]]},"published-print":{"date-parts":[[2019,12,1]]}},"URL":"https:\/\/doi.org\/10.1093\/trstmh\/try131","relation":{},"ISSN":["0035-9203","1878-3503"],"issn-type":[{"value":"0035-9203","type":"print"},{"value":"1878-3503","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,12]]},"published":{"date-parts":[[2019,1,31]]}}}